Novo Nordisk Profit Margin 2006-2018 | NVO

Current and historical gross, operating and net profit margin for Novo Nordisk (NVO) over the last 10 years. The current net profit margin for Novo Nordisk as of June 30, 2018 is 35.95%.
Novo Nordisk Annual Profit Margin Summary
Novo Nordisk Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $115.970B $16.962B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $360.770B 17.24
Pfizer (PFE) United States $250.556B 14.67
Novartis AG (NVS) Switzerland $192.442B 16.51
Merck (MRK) United States $186.199B 16.44
AbbVie (ABBV) United States $149.625B 14.62
Eli Lilly (LLY) United States $113.359B 20.98
Sanofi (SNY) France $105.440B 13.35
GlaxoSmithKline (GSK) United Kingdom $102.297B 13.66
Bristol-Myers Squibb (BMY) United States $99.527B 18.01
AstraZeneca (AZN) United Kingdom $96.554B 10.62